In addition, the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway is known to be abnormally activated in stroke [118], and this combination treatment appears to decrease this abnormal activation. This evidence concerns the gene STAT3 and Stroke.